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Background: The outbreak of COVID-19 has had a major impact on people’s daily life.
This study aimed to examine use of alcohol and addictive drugs during the COVID-19
outbreak in Norway and examine their association with mental health problems and
problems related to the pandemic.
Methods: A sample of 4,527 persons responded to the survey. Use of alcohol and
addictive drugs were cross-tabulated with sociodemographic variables, mental health
problems, and problems related to COVID-19. Logistic regression analyses were used
to examine the strength of the associations.
Results: Daily use of alcohol was associated with depression and expecting financial
loss in relation to the COVID-19 outbreak. Use of cannabis was associated with
expecting financial loss in relation to COVID-19. Use of sedatives was associated with
anxiety, depression, and insomnia. Use of painkillers was associated with insomnia and
self-reported risk of complications if contracting the coronavirus.
Conclusion: The occurrence of mental health problems is more important for an
understanding of the use of alcohol and addictive drugs during the COVID-19 outbreak
in Norway, compared to specific pandemic-related worries.
Keywords: alcohol, COVID-19, pandemic, population survey, substance use
INTRODUCTION
The outbreak of COVID-19 has had a major impact on people’s daily life. To prevent the spread
of the coronavirus disease, strict policies have emphasized keeping a physical distance to other
people, commonly known as social distancing (1, 2). These policies introduced abrupt changes
in economic life. Most travels and events were canceled, and non-vital businesses were closed.
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Consequently, financial problems suddenly became a reality for
many businesses, many employees were temporarily furloughed
from their jobs (3) and unemployment rates increased rapidly
(4). During this time, there has been a worldwide growing
concern that living under restrictive social distancing policies and
a general sense of uncertainty may have a profound impact on the
mental health of the population (5–8).
While the use of various pharmaceuticals generally reflects
the burden of disease in a society, the use of alcohol
and addictive drugs may also vary according to changes in
environmental conditions. Thus, the use of these substances may
be expected to rise during difficult times, such as the COVID-
19 pandemic. Studies of healthcare personnel during previous
infectious disease outbreaks have shown alcohol use to be higher
among those who worked in high-risk locations and situations,
compared to those who worked in low-risk situations (9, 10).
Moreover, during the current COVID-19 crisis, evidence of
increased alcohol use in the general population (11), as well as
a higher demand for cannabis products on the darknet (12), have
been found.
Recent studies based on data collected during the COVID-
19 pandemic have demonstrated associations between higher
alcohol use and middle age, higher income, job loss, stress,
sleep problems, and depression (13). Thus, the use of alcohol
may be associated with distal (sociodemographic factors, mental
health) and proximal factors (circumstances evoked by the
COVID-19 situation) alike. While mental health problems, such
as depression and anxiety, have been linked with increased
alcohol use during the pandemic (14), the consequences of the
COVID-19 outbreak (e.g., fear of virus transmission, loneliness,
and financial problems)may be related to increased use of alcohol
and other substances. Thus, to increase the understanding of
use of alcohol and addictive drugs in the COVID-19 context,
the explanatory power of a wider range of variables related to
the pandemic’s consequences needs to be considered. However,
we are unaware of similar population studies concerned with
the use of multiple addictive drugs during the COVID-19
outbreak. In addition, while recent studies have examined the
prevalence of use of alcohol and addictive drugs in the general
Norwegian population (15), such studies may not reflect the use
of such substances during extraordinary circumstances such as
the current pandemic. The aims of the study were to examine use
of alcohol and addictive drugs during the COVID-19 outbreak
and examine their association with mental health problems and
problems related to the pandemic.
MATERIALS AND METHODS
Design
A population-based cross-sectional study that dealt with
reactions in the Norwegian population after the COVID-19
outbreak (the CORONAPOP study) (16, 17), was conducted
with a web-link open to all citizens between April 8th, 2020
and May 20th, 2020. The web-link was hosted and disseminated
by several institutions, including Oslo University Hospital,
Sunnaas Rehabilitation Hospital, University of Oslo, and Oslo
Metropolitan University. The link to the survey was further
disseminated on social media platforms, such as Facebook,
Twitter, LinkedIn, and Instagram, by the individual researchers
and other individuals who wanted to share the link to the survey.
The study was also featured in national and local newspapers.
Sample
Norwegian citizens aged 18 years or older were invited to
participate. There were no exclusion criteria.
Measures
Sociodemographic and health-related data were collected as self-
report measures via the web-based survey. The survey employed
several measures identical to the ones used in the Norwegian
population health survey (the NORPOP study), which was
conducted as a postal survey in 2014–2015 (18–21). New
questions pertaining to the possible concerns and responses to
the COVID-19 pandemic were developed by the research group
at the time of the pandemic outbreak.
Sociodemographic Variables
Data were collected for age group (18–29 years, 30–39 years, 40–
49 years, 50–59 years, 60–69 years, and 70 years or older) gender
(male/female), highest completed education level (elementary
school, high school, <4 years of higher education, and 4 years
of higher education or more), employment status (working/in
education vs. not), cohabitation status (living with spouse or
partner vs. not), and living with children (living with children
under the age of 18 years vs. not). Size of place of residence
was categorized as <200 inhabitants, 200–19.999 inhabitants,
20.000–99.999 inhabitants, and 100.000 inhabitants or more. In
Norway, a significant part of the population lives in rural areas.
The categories were made considering that about 20–30% of the
population belong to each of the categories, and the NORPOP
study (18–21) used the same categories.
Substance Use
We used the phrase: “Use of alcohol and addictive drugs and
pharmaceuticals: have you used any of these?” Below was a list
containing alcohol, cannabis, sedatives, and painkillers/opioids,
with examples provided for sedatives and painkillers/opioids.
Response options were “no,” “sometimes,” “weekly,” “daily,”
and “several times daily.” Participants who reported that
they used alcohol daily were classified as daily drinkers.
Participants who reported that they (had) used cannabis,
sedatives or painkillers/opioids “sometimes” or more often, were
classified as “sometimes, weekly or daily” (S/W/D) users of the
relevant substance.
Mental Health Problems
We used the phrase: “Below is a list of health problems. Do you
have, or have you had, any of these?” Among the listed problems
were anxiety, depression, insomnia, and suicide thoughts. The
response alternatives were “no,” “yes previously, but not during
the last month” and “yes, during the last month.” Those who
confirmed having one or more of the listed health problems
during the last month were classified as currently having the
relevant mental health problems.
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Problems Related to the Pandemic
Relating to the COVID-19 situation, participants were asked to
respond “yes” or “no” to the following questions: (a) “Are you
suffering, or do you think you will be suffering, economic loss?”,
(b) “Have you been in quarantine or in isolation due to the
corona virus?”, (c) “Are you at risk of experiencing complications
from COVID-19?”, and (d) “Do you have friends or close family
that you worry about?” Participants who indicated “yes” on
any of these questions were classified as “experiencing/expecting
economic loss,” “experienced quarantine/isolation,” “risk of
complication,” and/or “worry about friends/family,” respectively.
Statistical Analyses
Frequencies and proportions (%) were calculated for all
categorical variables, and all were cross tabulated with the
occurrence of daily alcohol use, and with sometimes/weekly/daily
use of cannabis, sedatives, and painkillers. Single and multiple
logistic regression analyses were performed to assess associations
between sociodemographic variables, mental health problems
and COVID-19 related problems, and the use of substances.
In the multiple logistic regression analyses, all independent
variables were entered together in order to cancel out the
effects of covariation between the independent variables. Post-
hoc interaction analyses were performed for alcohol use to assess
whether significant associations were dependent on levels of
sociodemographic variables showing skewed distributions (i.e.,
age group, gender, education, and size of place of residence).
Interaction terms were included separately in a second step of the
analysis, while adjusting for sociodemographic variables, mental
health problems and COVID-19 related problems. For alcohol,
we distinguished between daily use (1) vs. less frequent or no
use (0). For cannabis, sedatives, and painkillers, we distinguished
between sometimes/weekly/daily use (1) vs. no use (0). Odds
ratio (OR) with 95% confidence interval (CI) was reported. IBM
SPSS Statistics version 26 (22) was used for statistical analyses,
and the significance level was set at 5%.
Ethics
The questionnaires were answered anonymously. Ethical
approval for conducting the study was granted from the Regional
Committee for Medical and Healthcare Ethics (REK no. 130447).
RESULTS
Sample Characteristics
The sociodemographic characteristics of the sample is displayed
in Table 1. More than half of the sample was under 40 years
of age, and the number of participants was lower in the
higher age groups. A majority were women (85.0%), had higher
education (75.5%) and were employed or in education (81.0%).
Current anxiety and depression were reported by 17.1 and
12.5%, respectively, while 31.8% reported insomnia. A smaller
proportion (3.6%) reported having had suicide thoughts during
the last month, while the larger proportion (61.7%) reported
having none of the listed mental health problems. With regards
to COVID-19, 25.3% expected to suffer financial loss, 28.3% had
been quarantined or in isolation and 23.4% reported to be at
risk of experiencing complications if contracting the coronavirus.
The large majority (83.9%) were worried about someone close
to them.
Associations Between Use of Alcohol and
Problems Related to Mental Health and the
COVID-19 Situation
As shown from the multiple logistic regression analysis in
Table 2, the odds of using alcohol daily were higher for those
of higher age (OR: 1.31, p < 0.001) and among those with
higher education (OR: 1.61, p < 0.05), and lower among women
than men (OR: 0.50, p < 0.01). Daily use of alcohol was also
associated with depression (OR: 3.40, p < 0.001) and with
expecting financial loss in relation to the COVID-19 outbreak
(OR: 1.66, p < 0.01).
The post-hoc analyses revealed a significant interaction
between age group and depression (p = 0.02). Cross tabulating
depression and daily alcohol use for each of the age groups
revealed a significant association for participants aged 18–29
years (φ = 0.15, p < 0.001), 30–39 years (φ = 0.15, p < 0.001),
and 40–49 years (φ = 0.13, p < 0.001), while the association
was not significant for participants in the older age groups. Thus,
depression was more strongly related to daily alcohol use in the
younger age groups. None of the other tested interaction terms
were found to be statistically significant.
Associations Between Use of Cannabis
and Problems Related to Mental Health
and the COVID-19 Situation
As shown from the multiple logistic regression analysis in
Table 3, the odds of using cannabis were lower for those of higher
age (OR: 0.53, p < 0.001) and among women (OR: 0.19, p <
0.001). The odds of using cannabis were higher among those
who expected financial loss in relation to the COVID-19 outbreak
(OR: 1.62, p < 0.05).
Associations Between Use of Sedatives
and Problems Related to Mental Health
and the COVID-19 Situation
As shown from the multiple logistic regression analysis in
Table 4, the odds of using sedatives were higher for those of
higher age (OR: 1.17, p < 0.01) and lower among those having
employment (OR: 0.58, p < 0.01). Use of sedatives was also
associated with anxiety (OR: 4.76, p < 0.001), depression (OR:
1.64, p < 0.01), and insomnia (OR: 2.15, p < 0.001).
Associations Between Use of Painkillers
and Problems Related to Mental Health
and the COVID-19 Situation
As shown from the multiple logistic regression analysis in
Table 5, the odds of using painkillers were lower for those
with higher education (OR: 0.64, p < 0.001) and those with
employment (OR: 0.66, p < 0.001). Use of painkillers was also
associated with insomnia (OR: 1.48, p < 0.001) and reporting
risk of complications if contracting the coronavirus (OR: 1.57,
p < 0.001).
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TABLE 1 | Sociodemographic characteristics of the sample (n = 4,527), among daily users of alcohol (n = 138) and among sometimes/weekly/daily users of cannabis
(n = 139), sedatives (n = 241), and painkillers (n = 579).
Characteristics Total sample Daily alcohol Sometimes/weekly/daily Sometimes/weekly/daily Sometimes/weekly/daily
cannabis sedatives painkillers
Age group n (%) n (%) n (%) n (%) n (%)
18–29 1156 (25.5) 20 (1.7) 70 (6.1) 61 (5.3) 121 (10.5)
30–39 1220 (26.9) 32 (2.6) 34 (2.8) 55 (4.5) 149 (12.2)
40–49 931 (20.6) 30 (3.2) 23 (2.5) 46 (4.9) 131 (14.1)
50–59 766 (16.9) 29 (3.2) 7 (0.9) 45 (5.9) 116 (15.1)
60–69 354 (7.8) 17 (4.8) 3 (0.8) 23 (6.5) 39 (11.0)
70 or above 100 (2.2) 10 (10.0) 2 (2.0) 11 (11.0) 23 (23.0)
Gendera
Male 659 (14.6) 37 (5.6) 52 (7.9) 39 (5.9) 98 (14.9)
Female 3850 (85.0) 101 (2.6) 87 (2.3) 200 (5.2) 479 (12.4)
Highest completed educationb
Elementary school 591 (13.1) 13 (2.2) 29 (4.9) 57 (9.6) 126 (21.3)
High school 514 (11.4) 14 (2.7) 23 (4.5) 33 (6.4) 84 (16.3)
Higher education <4 years 1376 (30.4) 45 (3.3) 38 (2.8) 66 (4.8) 167 (12.1)
Higher education ≥4 years 2041 (45.1) 66 (3.2) 48 (2.4) 84 (4.1) 202 (9.9)
Employment
Employed or in education 3667 (81.0) 100 (2.7) 103 (2.8) 141 (3.8) 396 (10.8)
Not employed and not in education 860 (19.0) 38 (4.4) 36 (4.2) 100 (11.6) 183 (21.3)
Cohabitation status
Living with spouse or partner 2714 (60.0) 86 (3.2) 61 (2.2) 126 (4.6) 354 (13.0)
Not living with spouse or partner 1813 (40.0) 52 (2.9) 78 (4.3) 115 (6.3) 225 (12.4)
Living with children <18 years
Living with children 1547 (34.2) 35 (2.3) 30 (1.9) 60 (3.9) 194 (12.5)
Not living with children 2980 (65.8) 103 (3.5) 109 (3.7) 181 (6.1) 385 (12.9)
Size of place of residencec
Rural (<200 inhabitants) 187 (4.1) 3 (1.6) 6 (3.2) 8 (4.3) 36 (19.3)
Village (200–19,999 inhabitants) 1141 (25.2) 27 (2.4) 27 (2.4) 76 (6.7) 161 (14.1)
Town (20,000–99,999 inhabitants) 1091 (24.1) 29 (2.7) 24 (2.2) 57 (5.2) 142 (13.0)
City (>100,000 inhabitants) 2098 (46.3) 79 (3.8) 81 (3.9) 99 (4.7) 238 (11.3)
aEighteen participants (0.4%) did not state gender.
bFive participants (0.1%) did not state education level.
cTen participants (0.2%) did not state size of place of residence.
DISCUSSION
This study examined use of alcohol and addictive drugs in
the Norwegian population during the COVID-19 outbreak and
examined the substance use in association with mental health
problems and problems related to the pandemic. The occurrence
of mental health problems was found to be more important
for an understanding of the use of alcohol and addictive drugs
during the COVID-19 outbreak, compared to specific pandemic-
related worries.
Daily use of alcohol was associated with expecting financial
loss in relation to the COVID-19 outbreak. Some people may
have felt that their lives had been turned upside down regardless
of the consequence for their personal economy, while others
have lost their jobs, or they lived in constant fear of losing
it (3). The expectance of financial loss may be frequently
occurring among people employed with private sector jobs
that were strongly affected by market fluctuations, which may
translate into an increased risk of losing their job. Many
businesses in Norway were temporarily closed at the onset
of COVID-19, resulting in a rapid increase in unemployment
rates (4). The consequences were particularly severe for people
employed in the transportation and tourism industries, for
which unemployment rates were twice as high compared to
other industries (4). Although one might assume a relationship
between the expectance of financial loss and depression,
the results substantiated an association between expecting
financial loss and daily use of alcohol that was independent
of depression.
Adjusted for all variables, daily use of alcohol retained its
association with depression. The detected association between
alcohol use and depression is in line with a range of studies
(23), including a recent Norwegian population study in which
having anxiety or depression was associated with daily alcohol
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TABLE 2 | Associations with daily use of alcohol.
Independent variables Crude Adjusted
OR 95%CI P OR 95%CI p
Age group 1.33 1.18–1.50 <0.001 1.31 1.14–1.51 <0.001
Female gender 0.45 0.31–0.66 <0.001 0.50 0.34–0.75 <0.01
Higher education 1.34 0.88–2.06 0.18 1.61 1.03–2.52 <0.05
Employment 0.60 0.41–0.88 <0.05 0.98 0.63–1.52 0.93
Anxiety 1.43 0.95–2.14 0.09 0.69 0.41–1.18 0.17
Depression 3.35 2.31–4.85 <0.001 3.40 2.06–5.62 <0.001
Insomnia 1.68 1.19–2.37 <0.01 1.18 0.78–1.78 0.43
Suicide thoughts 2.98 1.64–5.39 <0.001 1.71 0.86–3.38 0.12
Economic loss 1.82 1.28–2.59 <0.01 1.66 1.15–2.41 <0.01
Quarantine/isolation 1.33 0.93–1.90 0.12 1.41 0.98–2.03 0.07
Risk of complications 1.96 1.38–2.79 <0.001 1.31 0.88–1.95 0.19
Model fit p < 0.001
Cox Snell (Nagelkerke) 2.0% (8.5%)
Dependent variable is daily use of alcohol. Age group is 10-year intervals. Employment is being employed or in education. Anxiety, depression, insomnia, and suicide thoughts are having
the problem during the last month. Economic loss is expecting the COVID-19 situation to cause personal economic loss. Risk of complications is self-reported risk of complications in
the case of contracting the coronavirus.
TABLE 3 | Associations with use of cannabis.
Independent variables Crude Adjusted
OR 95%CI P OR 95%CI p
Age group 0.60 0.51–0.71 <0.001 0.53 0.44–0.63 <0.001
Female gender 0.27 0.19–0.38 <0.001 0.19 0.13–0.28 <0.001
Higher education 0.52 0.37–0.74 <0.001 0.71 0.49–1.03 0.07
Employment 0.66 0.45–0.97 <0.05 0.71 0.46–1.11 0.13
Anxiety 1.48 0.99–2.21 0.06 0.96 0.58–1.59 0.87
Depression 1.56 1.00–2.42 <0.05 1.06 0.60–1.89 0.85
Insomnia 1.61 1.14–2.27 <0.01 1.39 0.93–2.07 0.11
Suicide thoughts 1.46 0.67–3.17 0.34 0.75 0.31–1.80 0.52
Economic loss 2.17 1.54–3.06 <0.001 1.62 1.12–2.34 <0.05
Quarantine/isolation 1.36 0.95–1.94 0.09 1.18 0.82–1.71 0.37
Risk of complications 0.94 0.63–1.41 0.76 1.25 0.80–1.95 0.33
Model fit p < 0.001
Cox Snell (Nagelkerke) 3.1% (12.8%)
Dependent variable is use of cannabis sometimes, weekly or daily. Age group is 10-year intervals. Employment is being employed or in education. Anxiety, depression, insomnia, and
suicide thoughts are having the problem during the last month. Economic loss is expecting the COVID-19 situation to cause personal economic loss. Risk of complications is self-reported
risk of complications in the case of contracting the coronavirus.
use (24). Thus, use of alcohol appears to be relatively independent
from external circumstances. As demonstrated by Ertl et al. (25),
alcohol use in the context of mental health problems may be
linked with relief-oriented motives for drinking, as opposed to
reward-oriented motives. In their study, more psychopathology
was associated with relief-oriented drinkingmotives. It is possible
that relief-oriented drinking may increase during crises as many
people struggle with stress reactions to the crisis. The results
from the post-hoc interaction analyses suggest that this may more
often be the case among people in the younger age groups. A
study from Finland showed that more psychological symptoms
predicted a pattern of heavy drinking from adolescence to midlife
(26). Although the cross-sectional design of this study prohibits
concluding about the direction of the association, depression
appears to be consistently linked with heavy and frequent use
of alcohol during the COVID-19 outbreak, as shown in other
countries alike (13). Lastly, we noted the association between
higher education levels and higher odds of daily use of alcohol.
While this indicates that a high-frequent drinking pattern is
more common among those with higher education, it does
not necessarily point toward more alcohol-related problems in
this group.
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TABLE 4 | Associations with use of sedatives.
Independent variables Crude Adjusted
OR 95%CI P OR 95%CI p
Age group 1.11 1.01–1.21 <0.05 1.17 1.05–1.31 <0.01
Female gender 0.87 0.61–1.23 0.43 0.76 0.52–1.13 0.17
Higher education 0.52 0.39–0.68 <0.001 0.83 0.62–1.13 0.24
Employment 0.30 0.23–0.40 <0.001 0.58 0.42–0.80 <0.01
Anxiety 8.64 6.59–11.34 <0.001 4.76 3.36–6.74 <0.001
Depression 6.24 4.75–8.19 <0.001 1.64 1.15–2.34 <0.01
Insomnia 5.14 3.89–6.80 <0.001 2.15 1.54–2.99 <0.001
Suicide thoughts 5.57 3.74–8.31 <0.001 1.33 0.83–2.14 0.23
Economic loss 1.56 1.18–2.05 <0.01 0.99 0.72–1.34 0.93
Quarantine/isolation 1.00 0.75–1.34 0.99 0.85 0.62–1.17 0.32
Risk of complications 2.29 1.75–2.99 <0.001 1.30 0.95–1.79 0.10
Model fit p < 0.001
Cox Snell (Nagelkerke) 7.3% (21.3%)
Dependent variable is use of sedatives sometimes, weekly or daily. Age group is 10-year intervals. Employment is being employed or in education. Anxiety, depression, insomnia, and
suicide thoughts are having the problem during the last month. Economic loss is expecting the COVID-19 situation to cause personal economic loss. Risk of complications is self-reported
risk of complications in the case of contracting the coronavirus.
TABLE 5 | Associations with use of painkillers.
Independent variables Crude Adjusted
OR 95%CI P OR 95%CI p
Age group 1.12 1.05–1.19 <0.01 1.05 0.98–1.13 0.18
Female gender 0.81 0.64–1.03 0.08 0.86 0.67–1.10 0.22
Higher education 0.52 0.43–0.62 <0.001 0.64 0.52–0.78 <0.001
Employment 0.45 0.37–0.55 <0.001 0.66 0.53–0.82 <0.001
Anxiety 1.58 1.28–1.94 <0.001 1.01 0.77–1.32 0.95
Depression 1.85 1.47–2.32 <0.001 1.24 0.92–1.66 0.15
Insomnia 1.84 1.54–2.19 <0.001 1.48 1.20–1.81 <0.001
Suicide thoughts 1.86 1.26–2.75 <0.01 1.09 0.70–1.70 0.72
Economic loss 1.36 1.12–1.64 <0.01 1.13 0.92–1.39 0.23
Quarantine/isolation 1.13 0.93–1.37 0.21 1.09 0.89–1.32 0.41
Risk of complications 2.05 1.70–2.46 <0.001 1.57 1.27–1.93 <0.001
Model fit p < 0.001
Cox Snell (Nagelkerke) 3.2% (6.0%)
Dependent variable is use of painkillers sometimes, weekly or daily. Age group is 10-year intervals. Employment is being employed or in education. Anxiety, depression, insomnia,
and suicide thoughts are having the problem during the last month. Economic loss is expecting the COVID-19 situation to cause personal economic loss. Risk of complications is
self-reported risk of complications in the case of contracting the coronavirus.
Use of cannabis was associated with expecting financial loss
in relation to the COVID-19 outbreak. Cannabis use was also
associated with younger age, a finding which is in line with
previous Norwegian population studies (27). Generally, young
people are often employed in part-time jobs while undergoing
education—in Norway, one in three full-time students have part
time jobs (28). Moreover, they often have jobs in the retail and
service industries such as shops and restaurants, which might be
particularly affected by crises such as the COVID-19 outbreak.
Thus, people of young age are generally in a vulnerable economic
situation which may become even worse with the potential loss
of a job.
Use of sedatives was associated with anxiety, depression,
and insomnia. This result appears to reflect that sedatives are
commonly used pharmaceuticals for mental disorders in general
(29). It is also consistent with the findings in a recent general
population study from Norway (15), demonstrating higher
relative risk of a wide range of disorders, including anxiety,
depression and insomnia, for people who had used sedatives
sometimes or more often.
Use of painkillers was associated with insomnia and reporting
risk of complications if contracting the coronavirus. Sleep and
pain have been shown to have a bidirectional relationship—sleep
problems can be caused by pain, while better sleep can reduce
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pain (30). For people experiencing pain, the use of painkillers
can therefore be a logical means to regaining sleep. Use of
painkillers have also been shown to be associated with higher
risk of a wide range of diseases, including pulmonary disease
and cancer (15). As these diseases are often painful (31, 32) and
constitute increased risk of fatal outcome if the person is exposed
to COVID-19 infection, the occurrence of these and similar
pain-inducing diseases may contribute to explain the association
between perceived risk of complications and use of painkillers.
Study Limitations
The cross-sectional survey design precludes us from establishing
causal relationships between the variables under study; the study
is therefore limited in its mere detection of statistical associations
between mental health problems and problems relating to the
COVID-19, and the use of alcohol and addictive drugs. To
overcome some of the limitations related to a cross-sectional
study design, future studies may include follow-up assessments
that will allow for studying how the use of alcohol and drugs
develops over time, and how their use may be related to a range
of specific exposures.
While a range of variables were used as possible predictors
of substance use, other variables—not accounted for in this
study—might have added to the explanatory power of the
statistical model. Such variables may include confinement at
home, working from home, spending more time together at
home, home conflicts, and having children at home during
daytime. Possibly, the consumption of substances would be
related to these situations. Alternatively, these situations may
increase the risk of mental health problems, which in turn was
found to be related to use of substances.
The use of standard mental health measurements might have
been a preferred option to our use of single-item scales, and
future studies may include the use of standardized measures such
as the Alcohol Use Disorder Identification Test (AUDIT) (33, 34).
The recently developed Fear of COVID-19 Scale has shown
to be promising (35), and the Norwegian version of the scale
may also be serviceable (36). However, standard measurements
are generally longer and place a larger burden on participants,
especially when used in context of a larger survey. Moreover,
studies have demonstrated that the use of single-item measures
can be a valid and reliable option for measuring mental health
phenomena (37–40). Similarly, with regards to alcohol use,
measuring the quantity of drinking in addition to the frequency
of drinkingmay have provided amore comprehensive estimate of
risky drinking. Nonetheless, evidence suggests that high-frequent
drinking is associated with increased health risk, even in the case
of moderate consumption (41, 42).
The recruitment strategy was based on disseminating the link
to the survey via various social media, and the strategy makes
generalizing the results to the general population impossible
due to selection bias. In fact, the sample was dominated by
young, urban, and highly educated persons, and the vast majority
were female. Among the general population in Norway, a
significant part lives in rural areas, but this rural population was
underrepresented in this study. Therefore, one should be cautious
when comparing prevalence rates related to the use of alcohol
and addictive drugs to previously established prevalence rates in
the general population. In comparison to previously established
prevalence rates (15, 24), it appears that the rate of daily alcohol
use is similar, whereas the rates of “sometimes/weekly/daily” use
of cannabis, sedatives, and painkillers are lower in this study.
However, it has been argued that skewed samples are more
prone to affect prevalence rates of substance use, while less
prone to affect associations between predictors and substance use
outcomes (43, 44). The post-hoc interaction analyses conducted
with regards to alcohol use in this study were largely in line
with this view. The relatively large sample size and the possibility
to compare the results from the early phase of the COVID-19
outbreak with a previous general population study (NORPOP)
are strengths of the study. However, we stress that the study was
conducted exclusively with participants living in Norway, which
makes it impossible to transfer the conclusions of the study to
other countries. Similar studies conducted in other countries and
settings are therefore warranted.
CONCLUSIONS
Compared to specific pandemic-related worries, the occurrence
of mental health problems was found to be more important for
the use of alcohol and addictive drugs during the early stage of
the COVID-19 outbreak in Norway. Depression was associated
with daily use of alcohol, while several mental health problems
including depression, anxiety, and insomnia were associated with
use of sedatives. Worries specifically related to the COVID-19
outbreak were of less importance in relation to the use of
alcohol and addictive drugs. While the results of a population
survey do not warrant direct application to individual clients
with alcohol or drug problems, the study indicates that mental
health problems constitute an important context for the use
of alcohol and addictive drugs during the pandemic. Public
health initiatives aimed at reducing harmful use of alcohol and
drugs should therefore consider the occurrence of mental health
problems in the targeted population. Conversely, increased
incidence of mental health problems in a populationmay warrant
further assessment of service needs related to substance use.
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